POSTHERPETIC NEURALGIA
Clinical trials for POSTHERPETIC NEURALGIA explained in plain language.
Never miss a new study
Get alerted when new POSTHERPETIC NEURALGIA trials appear
Sign up with your email to follow new studies for POSTHERPETIC NEURALGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for lingering shingles pain
Symptom relief CompletedThis study tested a new drug called LX9211 to see if it can reduce pain in people with postherpetic neuralgia, a type of nerve pain that continues after a shingles rash heals. About 79 adults with moderate to severe pain for at least 3 months took either the drug or a placebo for…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
New shingles pain drug shows promise in early trial
Symptom relief CompletedThis study tested a single dose of an experimental drug called KAI-1678 in 23 adults with long-term nerve pain from shingles (postherpetic neuralgia). The goal was to see if it could reduce pain within 6 hours compared to a placebo or an active painkiller. The trial is complete, …
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE2 • Sponsor: KAI Pharmaceuticals • Aim: Symptom relief
Last updated May 01, 2026 15:56 UTC
-
Nerve stimulation study aims to predict best candidates for shingles pain relief
Knowledge-focused CompletedThis study involved 77 adults with long-term nerve pain from shingles (postherpetic neuralgia). Researchers used a medical device to stimulate nerve roots near the spine and tracked pain levels and quality of life. The goal was to identify which patient types respond best, so the…
Matched conditions: POSTHERPETIC NEURALGIA
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:04 UTC